Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has completed the first group of therapists involved in their training program for psilocybin-assisted clinical therapy.
McIntyre says the cohort of 20 qualified therapists come from diverse psychiatry and psychotherapy backgrounds. This program was implemented by the Braxia Institute and is able to develop, train, and support qualified, independent medical physicians, psychologists and psychotherapists skilled in safe and effective psilocybin-assisted therapy for patients with depression.